Quality assurance and improvement in oncology using guideline-derived quality indicators - results of gynaecological cancer centres certified by the German cancer society (DKG).


Journal

Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060

Informations de publication

Date de publication:
May 2023
Historique:
received: 17 03 2022
accepted: 09 05 2022
medline: 14 4 2023
pubmed: 4 6 2022
entrez: 3 6 2022
Statut: ppublish

Résumé

Based on the example of Gynaecological Cancer Centres (GCCs) certified by the German Cancer Society, this study evaluates the results of medical-guideline-derived quality indicators (QIs) for cervical cancer (CC) and ovarian cancer (OC), examines the development of indicator implementation over time as well as the status of guideline-compliant care and identifies improvement measures. QI results for patients with CC and OC treated in GCCs between 2015 and 2019 are analysed. The median, overall proportion and standard deviation of each QI were calculated. Two-sided Cochran-Armitage tests were applied. QIs are divided into two categories: process-organization (PO-QIs) and treatment-procedures (TP-QIs), to allow a differentiated analysis for identifying improvement measures. PO-QIs that reflect the implementation of processes and structures show a high degree of application. PO-QIs have a tremendous influence on the quality of care and are easy to implement through SOPs. TP-QIs report on treatments that are performed in the GCC. TP-QIs that report on systemic therapies reach a plateau where the guideline is known, but patient-related-factors meaningfully prevent further increase. TP-QIs that report on surgical interventions fluctuate. The most relevant factors are practitioners' personal skills. Besides the discussion of results amongst peers during the audit, improvement measures could include surgical courses or coaching. The analysis shows that a combination of different measures is necessary to anchor quality sustainably in health care and thus improve it.

Identifiants

pubmed: 35657567
doi: 10.1007/s00432-022-04060-8
pii: 10.1007/s00432-022-04060-8
pmc: PMC10097788
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1703-1715

Informations de copyright

© 2022. The Author(s).

Références

Arch Gynecol Obstet. 2014 Jan;289(1):7-12
pubmed: 24220845
Arch Gynecol Obstet. 2019 Aug;300(2):383-388
pubmed: 31062148
Geburtshilfe Frauenheilkd. 2014 Mar;74(3):260-266
pubmed: 25061235
Gynecol Oncol. 2003 Apr;89(1):4-8
pubmed: 12694647
Geburtshilfe Frauenheilkd. 2016 Apr;76(4):369-376
pubmed: 27134291
Br J Obstet Gynaecol. 1999 Nov;106(11):1130-6
pubmed: 10549956
Gynecol Oncol. 2009 Feb;112(2):422-36
pubmed: 18990435
Gynecol Oncol. 2009 Dec;115(3):334-8
pubmed: 19766295
Am J Obstet Gynecol. 2011 Sep;205(3):225.e1-7
pubmed: 21684517
BMC Cancer. 2017 Dec 14;17(1):850
pubmed: 29241445
Z Evid Fortbild Qual Gesundhwes. 2015;109(6):437-44
pubmed: 26474648
JAMA. 1998 Nov 25;280(20):1747-51
pubmed: 9842949

Auteurs

E Griesshammer (E)

Charité-University Hospital Berlin, Berlin, Germany. griesshammer@krebsgesellschaft.de.
German Cancer Society e.V., 14057, Berlin, Germany. griesshammer@krebsgesellschaft.de.

S Wesselmann (S)

German Cancer Society e.V., 14057, Berlin, Germany.

M W Beckmann (MW)

Department of Obstetrics and Gynecology, University of Erlangen, 91054, Erlangen, Germany.

C Dannecker (C)

Department of Obstetrics and Gynecology, University Hospital Augsburg, 86156, Augsburg, Germany.

U Wagner (U)

Clinic for Gynecology, Gynecological Oncology and Gynecological Endocrinology, University Hospital of Giessen and Marburg (UKGM), Marburg, Germany.

N T Sibert (NT)

German Cancer Society e.V., 14057, Berlin, Germany.

R Armbrust (R)

Department of Gynecology with Center for Oncological Surgery, Charité-University Hospital Berlin, Berlin, Germany.

J Sehouli (J)

Department of Gynecology with Center for Oncological Surgery, Charité-University Hospital Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH